Estrella Immunopharma Inc...

NASDAQ: ESLA · Real-Time Price · USD
0.90
0.04 (4.60%)
At close: Aug 15, 2025, 2:59 PM

Estrella Immunopharma Ratios and Metrics

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Dec 31, 2022 Jun 30, 2022
PE Ratio
-5.3 -59.53 -34.71
PEG Ratio
-0.23 1.44 -0.03
PS Ratio
n/a n/a n/a
PB Ratio
9.06 8.39 -56.26
P/FCF Ratio
-2.41 -56.81 -40.57
P/OCF Ratio
-2.41 -56.81 -40.57
OCF/S Ratio
n/a n/a n/a
Debt / Equity Ratio
n/a 0.07 n/a
Quick Ratio
24.65 0.05 5.20
Current Ratio
24.65 0.05 5.20
Asset Turnover
n/a n/a n/a
Interest Coverage
n/a n/a n/a
Return on Equity
-1.71 -0.14 1.62
Return on Assets
-1.64 -0.1 -0.34
Return on Invested Capital
-1.71 -0.18 -0.03
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
n/a n/a n/a
Net Profit Margin
n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a
Operating Profit Margin
n/a n/a n/a
FCF Margin
n/a n/a n/a
EBITDA Margin
n/a n/a n/a